Total Payments
$324.94
2023 Payments
$17.60
Companies
5
Transactions
22
Medicare Patients
4,872
Medicare Billing
$922,837
Payment Breakdown by Category
Food & Beverage$324.94 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $324.94 | 22 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $255.19 | 18 | $0 (2023) |
| Boston Scientific Corporation | $21.24 | 1 | $0 (2020) |
| Biohaven Pharmaceuticals, Inc. | $19.51 | 1 | $0 (2021) |
| Allergan, Inc. | $17.14 | 1 | $0 (2020) |
| Sunovion Pharmaceuticals Inc. | $11.86 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $17.60 | 1 | ABBVIE INC. ($17.60) |
| 2022 | $60.09 | 3 | ABBVIE INC. ($60.09) |
| 2021 | $197.01 | 15 | AbbVie Inc. ($177.50) |
| 2020 | $38.38 | 2 | Boston Scientific Corporation ($21.24) |
| 2017 | $11.86 | 1 | Sunovion Pharmaceuticals Inc. ($11.86) |
All Payment Transactions
22 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/29/2023 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $17.60 | General |
| Category: NEUROSCIENCE | ||||||
| 08/16/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $16.95 | General |
| Category: NEUROSCIENCE | ||||||
| 03/24/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $16.33 | General |
| Category: NEUROSCIENCE | ||||||
| 01/12/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $26.81 | General |
| Category: NEUROSCIENCE | ||||||
| 12/03/2021 | AbbVie Inc. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $4.82 | General |
| Category: NEUROSCIENCE | ||||||
| 10/26/2021 | AbbVie Inc. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $15.53 | General |
| Category: NEUROSCIENCE | ||||||
| 10/16/2021 | AbbVie Inc. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $20.06 | General |
| Category: NEUROSCIENCE | ||||||
| 10/15/2021 | AbbVie Inc. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $11.06 | General |
| Category: NEUROSCIENCE | ||||||
| 09/27/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $22.91 | General |
| Category: NEUROSCIENCE | ||||||
| 09/09/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $15.21 | General |
| Category: NEUROSCIENCE | ||||||
| 09/09/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $0.22 | General |
| Category: NEUROSCIENCE | ||||||
| 08/26/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $10.45 | General |
| Category: NEUROSCIENCE | ||||||
| 07/15/2021 | Biohaven Pharmaceuticals, Inc. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $19.51 | General |
| Category: PRIMARY CARE | ||||||
| 06/30/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $10.30 | General |
| Category: NEUROSCIENCE | ||||||
| 06/30/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $8.71 | General |
| Category: NEUROSCIENCE | ||||||
| 06/23/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $16.43 | General |
| Category: NEUROSCIENCE | ||||||
| 04/22/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $27.72 | General |
| Category: NEUROSCIENCE | ||||||
| 04/15/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $6.30 | General |
| Category: NEUROSCIENCE | ||||||
| 03/04/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $7.78 | General |
| Category: NEUROSCIENCE | ||||||
| 06/05/2020 | Allergan, Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $17.14 | General |
| Category: NEUROSCIENCE | ||||||
| 04/20/2020 | Boston Scientific Corporation | WATCHMAN (Device) | Food and Beverage | In-kind items and services | $21.24 | General |
| Category: STRUCTURAL HEART | ||||||
| 08/31/2017 | Sunovion Pharmaceuticals Inc. | APTIOM (Drug) | Food and Beverage | In-kind items and services | $11.86 | General |
| Category: CNS | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 1,275 | 3,999 | $345,801 | $257,211 |
| 2022 | 8 | 1,294 | 3,474 | $311,646 | $236,121 |
| 2021 | 10 | 1,268 | 3,371 | $302,600 | $236,896 |
| 2020 | 10 | 1,035 | 2,921 | $253,357 | $192,609 |
Total Patients
4,872
Total Services
13,765
Medicare Billing
$922,837
Procedure Codes
36
All Medicare Procedures & Services
36 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 293 | 1,710 | $117,623 | $88,601 | 75.3% |
| 20553 | Injection of trigger points, 3 or more muscles | Office | 2023 | 186 | 1,397 | $102,095 | $75,764 | 74.2% |
| 95911 | Nerve conduction, 9-10 studies | Office | 2023 | 167 | 168 | $42,608 | $30,873 | 72.5% |
| 95910 | Nerve conduction, 7-8 studies | Office | 2023 | 126 | 128 | $27,265 | $19,749 | 72.4% |
| 95885 | Needle measurement of electrical activity in arm or leg muscles, limited study | Office | 2023 | 207 | 289 | $20,319 | $15,874 | 78.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 111 | 111 | $17,323 | $13,296 | 76.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 136 | 147 | $13,481 | $9,342 | 69.3% |
| 96116 | Exam of neurobehavioral status, first hour | Office | 2023 | 49 | 49 | $5,089 | $3,713 | 73.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 276 | 1,423 | $97,799 | $73,003 | 74.6% |
| 20553 | Injection of trigger points, 3 or more muscles | Office | 2022 | 177 | 1,122 | $82,138 | $62,286 | 75.8% |
| 95911 | Nerve conduction, 9-10 studies | Office | 2022 | 165 | 165 | $41,842 | $32,071 | 76.6% |
| 95910 | Nerve conduction, 7-8 studies | Office | 2022 | 148 | 148 | $31,370 | $23,855 | 76.0% |
| 95885 | Needle measurement of electrical activity in arm or leg muscles, limited study | Office | 2022 | 233 | 304 | $21,350 | $16,761 | 78.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 123 | 123 | $19,269 | $14,749 | 76.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 127 | 144 | $13,206 | $9,705 | 73.5% |
| 96116 | Exam of neurobehavioral status, first hour | Office | 2022 | 45 | 45 | $4,673 | $3,691 | 79.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 315 | 1,452 | $99,801 | $76,846 | 77.0% |
| 20553 | Injections of trigger points in 3 or more muscles | Office | 2021 | 181 | 1,069 | $78,473 | $61,632 | 78.5% |
| 95910 | Nerve transmission studies, 7-8 studies | Office | 2021 | 148 | 158 | $33,631 | $26,695 | 79.4% |
| 95911 | Nerve transmission studies, 9-10 studies | Office | 2021 | 129 | 130 | $32,957 | $26,328 | 79.9% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 154 | 154 | $24,037 | $18,822 | 78.3% |
| 95885 | Needle measurement and recording of electrical activity of muscles of arm or leg limited study | Office | 2021 | 215 | 282 | $19,794 | $15,806 | 79.9% |
| 96116 | Neurobehavioral status examination by qualified health care professional with interpretation and report, first 60 minutes | Office | 2021 | 58 | 58 | $6,023 | $4,736 | 78.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 44 | 44 | $4,094 | $3,049 | 74.5% |
| 95816 | Measurement and recording of brain wave (eeg) activity, awake and drowsy | Office | 2021 | 12 | 12 | $3,548 | $2,838 | 80.0% |
About Dr. James Liguori, DO
Dr. James Liguori, DO is a Neuromusculoskeletal Medicine & OMM healthcare provider based in New Hyde Park, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/27/2006. The National Provider Identifier (NPI) number assigned to this provider is 1609890862.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. James Liguori, DO has received a total of $324.94 in payments from pharmaceutical and medical device companies, with $17.60 received in 2023. These payments were reported across 22 transactions from 5 companies. The most common payment nature is "Food and Beverage" ($324.94).
As a Medicare-enrolled provider, Liguori has provided services to 4,872 Medicare beneficiaries, totaling 13,765 services with total Medicare billing of $922,837. Data is available for 4 years (2020–2023), covering 36 distinct procedure/service records.
Ad
Practice Information
- Specialty Neuromusculoskeletal Medicine & OMM
- Location New Hyde Park, NY
- Active Since 07/27/2006
- Last Updated 11/24/2020
- Taxonomy Code 204D00000X
- Entity Type Individual
- NPI Number 1609890862
Products in Payments
- UBRELVY (Drug) $169.98
- QULIPTA (Drug) $102.35
- WATCHMAN (Device) $21.24
- NURTEC ODT (Drug) $19.51
- APTIOM (Drug) $11.86
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.